Table 1.

The clinical data of non-critical COVID-19 patients

	Total COVID-19 patients (n=50)	Mild COVID-19 patients (n=10)	Common COVID-19 patients (n=40)	P value
Age (years)	34 (25-42)	34 (22-36.5)	34.5 (25-47)	0.451
Sex				1
Male	17 (34%)	3 (30%)	14 (35%)
Female	33 (66%)	7 (70%)	26 (65%)
Exposure history				1
Yes	36 (72%)	7 (70%)	29 (72.5%)
No	14 (28%)	3 (30%)	11 (27.5%)
Chronic comorbidities
Chronic lung disease	4 (8%)	1 (10%)	3 (7.5%)
High blood pressure	1 (2%)	0 (0%)	1 (2.5%)
Postoperative tumor	2 (4%)	0 (0%)	2 (5%)
Diabetes	1 (2%)	0 (0%)	1 (2.5%)
Chronic kidney disease	1 (2%)	0 (0%)	1 (2.5%)
Allergic rhinitis	2 (4%)	0 (0%)	2 (5%)
Viral hepatitis	4 (8%)	0 (0%)	4 (10%)
Hyperlipidemia	1 (2%)	0 (0%)	1 (2.5%)
No comorbidities	35 (70%)	9 (90%)	26 (65%)	0.246
Signs and symptoms
Fever	33 (66%)	5 (50%)	29 (72.5%)	0.277
Cough	35 (70%)	3 (30%)	32 (80%)	0.004
Expectoration	4 (8%)	1 (10%)	3 (7.5%)	0.603
Sore throat	13 (26%)	0 (0%)	13 (32.5%)	0.046
Chest pain, Chest distress, breathlessness	11 (22%)	1 (10%)	10 (25%)	0.424
Muscle aches	5 (10%)	1 (10%)	4 (10%)	1
Fatigue	3 (6%)	1 (10%)	2 (5%)	0.496
Gastrointestinal symptoms	4 (8%)	1 (10%)	3 (7.5%)	1
Headache and dizziness	4 (8%)	1 (10%)	3 (7.5%)	1
Chills	5 (10%)	0 (0%)	5 (12.5%)	0.569
Runny nose	3 (6%)	1 (10%)	2 (5%)	0.496
Time interval from symptom onset to first visit (days)	2 (1, 4)	1 (1, 2)	2 (1, 4)	0.309
Course of disease (days)	12.5 (10, 16)	8.5 (7, 18.3)	14 (10, 19.5)	0.734